Netherton Syndrome

WALTHAM, Mass. — September 9, 2026 Revvity, Inc. announced that it has entered into a definitive agreement to acquire...

ASHBURN, Va. — September 8, 2026 Quoin Pharmaceuticals Ltd. announced that the U.S. Food and Drug Administration (FDA) has...

ASHBURN, Va., June 16, 2026 Quoin Pharmaceuticals announced a positive clinical update from its ongoing pediatric Netherton Syndrome (NS)...